Reclassifying erectile dysfunction drug sildenafil as a pharmacy medicine would not be such a huge leapSubscription
Allowing pharmacists to sell sildenafil would offer men a convenient, safe, and perhaps less intimidating, channel for seeking professional advice and treatment for erectile dysfunction.
We outline some of the issues pharmacists might like to consider before they cast their vote in the UK general election on 8 June 2017.
Sustainability and transformation plans (STPs) are the blueprints for the future of the NHS, setting out how 44 areas across England — identified as geographical STP ‘footprints’ — plan to get the best health outcomes for their populations from increasingly stretched financial resources.
It is a decade since the National Patient Safety Agency issued guidance on medicines packaging design in a bid to reduce the risk of dispensing errors. But medicines that sound alike or look alike are still responsible for a large proportion of errors. A collaborative approach between manufacturers, regulators and pharmacy organisations is required to tackle the problem.
Getting drugs across the blood-brain barrier could be key to developing more successful therapies to treat central nervous system disorders, such as Alzheimer’s disease, depression and epilepsy. Scientists are investigating a number of ways to achieve this, from using Trojan horses to smuggle drugs across the barrier, to temporary disruption of the barrier using ultrasound, to allow drugs into the brain.
There has been negative publicity in the national press about drug manufacturers increasing the price of some medicines significantly: so called ‘price gouging’. These increased prices are then passed on to the NHS, and lead to headlines quoting multi-million pound figures.
NHS cyber attack: views from the front lineSubscription
The Pharmaceutical Journal spoke to pharmacists to find out how the cyber attack of 12 May 2017 affected their service provision and what they did to manage the situation.
Q&A: How to ensure access to essential medicines for those in low and middle-income countriesSubscription
Andy Gray and Hans Hogerzeil, co-chairs of the The Lancet Commission on Essential Medicines, discuss the analysis on the cost of providing essential medicines to people in low and middle-income countries.
Pertussis (whooping cough) is a highly contagious, acute bacterial infection. It can affect people of all ages, but is especially dangerous in vulnerable groups, such as unimmunised infants.
Anticipatory prescribing enables patients in the last days and weeks of their lives to have their symptoms managed at home. Pharmacists are ideally positioned to provide practical support and advice to other healthcare professionals on the prescribing and administration of anticipatory medicines and to facilitate timely supply.
Simon Harris describes his experience in developing and delivering a range of education programmes for pharmacy professionals, as well as the reasons why he became a tutor, and the benefits this has brought to his career.
With public health bodies and clinical commissioning groups now seeking single organisations to manage local services, Steve Hemsley examines the benefits for community pharmacists and pharmacies when creating pharmacy provider companies to tender for new services, as well as the risks and challenges posed by this new approach.
The multidisciplinary holistic assessment and rapid investigation team assesses, investigates and treats referred patients with multiple complex medical and rehabilitation needs. Clinical pharmacist Rania Hallaq talks about the demands of running a clinic, problem-solving and managing complex patients.
The risk of having a heart attack is 17 times higher in the week after a respiratory infection and remains high for a month, say Australian researchers.
The Company Chemists’ Association (CCA), a trade body that represents multiple pharmacy chains in the UK, is planning to set up a ‘crisis team’ in the wake of the malware attack that hit the NHS on 12 May 2017.
Losing confidential personal data when transferring patient records is one of the data protection breaches committed by community pharmacists, according to the Information Commissioner’s Office’s good practice department.
An experimental drug being tested as a treatment for severe asthma by pharmaceutical company AstraZeneca has failed to meet its primary endpoint of significantly reducing the annual rate of asthma exacerbations in the first of two phase III studies.
Analysis of data from nearly 450,000 patients reveals that celecoxib, diclofenac, ibuprofen, naproxen and rofecoxib all increased heart attack risk, with the greater risk of heart attack becoming apparent in the first week of treatment.
News in Brief
Certain psychotropic drugs used to treat post-traumatic stress disorder (PTSD) increase the risk of developing dementia, including in patients who do not have PTSD but take the drugs for other conditions, study results published in the Journal of the American Geriatrics Society show.
A drug which faced controversy over its unlicensed use in treating alcohol addiction might also be useful in stuttering, researchers have found.
Researchers who analysed 40 date-expired EpiPens and EpiPen Juniors have discovered that they were still effective beyond the stated expiry date.
The European Medicines Agency (EMA) and the European Commission (EC) has issued a notice to drug companies reminding them of their legal duties regarding any medicines that have been approved centrally in light of the UK leaving the EU.
Source: Shutterstock Action on Smoking and Health, which carried out the poll, says the findings highlight a communication challenge about the risk of vaping compared to smoking tobacco
Results from a pilot study of pharmacy-supported medicines administration on hospital wards have revealed that the practice did not lead to a reduction in the number of omitted doses.
The General Pharmaceutical Council’s (GPhC) new standards for pharmacy professionals will come into effect on 12 May 2017.
Restricting pharmaceutical company representatives from directly promoting their products to doctors reduces prescription of those products, a US study has found.
The first drug of its kind to be made available in the United States for children with a specific form of the inherited disorder, Batten disease, has been approved by the US Food and Drug Administration (FDA).
Problem with registering for NHSmailSubscription
RPS board members must champion our aspirationsSubscription